IL4 and fatty liver disease: While PPARγ, rather than PPARδ, is essential for initiating the metabolic shift in response to IL-4, the deletion of either isoform has been demonstrated to hinder IL-4-triggered alternative macrophage activation, leading to insulin resistance and the development of hepatic steatosis (115, 116).